Complete response in patients with locally advanced rectal cancer after neoadjuvant treatment with nivolumab

Introduction: PD-1 inhibitors have been approved for the treatment of dMMR patients with metastatic colorectal cancer, but the efficacy of neoadjuvant treatment with PD-1 in dMMR locally advanced rectal cancer (LARC) patients has not yet been defined. Patients and methods: Two patients with LARC rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jianwei, Cai, Jian, Deng, Yanhong, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844302/
https://www.ncbi.nlm.nih.gov/pubmed/31741760
http://dx.doi.org/10.1080/2162402X.2019.1663108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844302/
https://www.ncbi.nlm.nih.gov/pubmed/31741760
http://dx.doi.org/10.1080/2162402X.2019.1663108

Ejemplares similares